Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2014

01.07.2014 | Article

A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm

verfasst von: S. Lencot, B. Cabaret, G. Sauvage, C. Laurans, E. Launay, J.-L. Orsonneau, J. Caillon, C. Boscher, J.-C. Roze, C. Gras-Le Guen

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Diagnostic of early-onset neonatal infection (EONI) remains an emergency. Recent studies underline the potential benefit of using Procalcitonin (PCT) in early diagnosis of bacterial infections in neonates. The aim of this study was to evaluate the diagnostic value of an umbilical blood cord PCT based algorithm in newborns suspected of EONI. The diagnostic value of the PCT based algorithm was compared to the French one currently in use by analyzing an 18-months database of newborns suspected of EONI in University Hospital of Nantes from March 2011 to September 2012. Among the 2,408 (40.8 %) newborns suspected of infection during this period, 2,366 were included in the study. The incidence of EONI was 3.4‰ (n = 20). There was no significant difference between the sensibilities of the PCT based algorithm and the current algorithm (90 %, respectively, 95%CI 76.9–100 versus 85.4–100; p = 0.90) and between their specificities (respectively 91.7 % (90.6–92.8) versus 87.4 % (86–88.7); p = 0.25). The antibiotic treatment rate would be significantly reduced with the PCT based algorithm [211 i.e. 8.9 % (7.8–10) versus 314 i.e. 13.3 % (11.9–14.7) in the current algorithm; p < 0.005] and less biological analysis would be performed [301 i.e. 12.7 % (11.4–14) versus 937 i.e. 39.6 % (37.6–41.6); p < 0.005]. Blood cord PCT seems to be a new and efficient marker to guide neonatologists taking care of newborns suspected of EONI. The PCT algorithm seems to be a safe alternative in diagnosis of EONI, allowing detection of EONI significantly as well as the current algorithm, without resulting in a substantially higher number of missed infections. These results have to be confirmed by a multicentric validation study.
Literatur
2.
Zurück zum Zitat Seale AC, Mwaniki M, Newton CR, Berkley JA (2009) Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 9(7):428–438PubMedCrossRefPubMedCentral Seale AC, Mwaniki M, Newton CR, Berkley JA (2009) Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 9(7):428–438PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Koenig JM, Keenan WJ (2009) Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin N Am 56(3):689–708CrossRef Koenig JM, Keenan WJ (2009) Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin N Am 56(3):689–708CrossRef
4.
Zurück zum Zitat CDC (2009) Trends in perinatal group B streptococcal disease—United States, 2000–2006. MMWR 58(5):109–112 CDC (2009) Trends in perinatal group B streptococcal disease—United States, 2000–2006. MMWR 58(5):109–112
5.
Zurück zum Zitat Schrag S, Gorwitz R, Schuchat A (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1–22PubMed Schrag S, Gorwitz R, Schuchat A (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1–22PubMed
6.
Zurück zum Zitat Verani JR, McGee L, Schrag SJ (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36PubMed Verani JR, McGee L, Schrag SJ (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36PubMed
7.
Zurück zum Zitat Puopolo KM, Madoff LC, Eichenwald EC (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115(5):1240–1246PubMedCrossRef Puopolo KM, Madoff LC, Eichenwald EC (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115(5):1240–1246PubMedCrossRef
8.
Zurück zum Zitat ANAES (2001) Prévention anténatale du risque infectieux bactérien néonatal précoce. ANAES, Haute Autorité de santé, France ANAES (2001) Prévention anténatale du risque infectieux bactérien néonatal précoce. ANAES, Haute Autorité de santé, France
9.
Zurück zum Zitat ANAES (2002) Diagnostic et traitement curatif de l’infection bactérienne précoce du nouveau-né. ANAES, Haute Autorité de santé, France ANAES (2002) Diagnostic et traitement curatif de l’infection bactérienne précoce du nouveau-né. ANAES, Haute Autorité de santé, France
11.
Zurück zum Zitat Sadeghi K, Berger A, Langgartner M et al (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195(2):296–302PubMedCrossRef Sadeghi K, Berger A, Langgartner M et al (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195(2):296–302PubMedCrossRef
12.
Zurück zum Zitat Polin RA, Committee on Fetus and Newborn (2012) Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129(5):1006–1015PubMedCrossRef Polin RA, Committee on Fetus and Newborn (2012) Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129(5):1006–1015PubMedCrossRef
13.
14.
15.
Zurück zum Zitat Didier C, Kuhn P (2012) Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 171:681–687PubMedCrossRef Didier C, Kuhn P (2012) Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 171:681–687PubMedCrossRef
16.
Zurück zum Zitat Cotten CM, Taylor S, Benjamin DK Jr et al (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1):58–66PubMedCrossRefPubMedCentral Cotten CM, Taylor S, Benjamin DK Jr et al (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1):58–66PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Neu J (2007) Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 65(6 Pt 1):282–285PubMedCrossRef Neu J (2007) Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 65(6 Pt 1):282–285PubMedCrossRef
18.
Zurück zum Zitat Penders J, Thijs C, van den Brandt PA et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56(5):661–667PubMedCrossRefPubMedCentral Penders J, Thijs C, van den Brandt PA et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56(5):661–667PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Russell SL, Finlay BB (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep, Canada Russell SL, Finlay BB (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep, Canada
20.
Zurück zum Zitat Schuetz P, Christ-Crain M, Thomann R et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef Schuetz P, Christ-Crain M, Thomann R et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef
21.
Zurück zum Zitat Berg P, Lindhardt BØ (2012) The role of procalcitonin in adult patients with community-acquired pneumonia—a systematic review. Dan Med J 59(3):A4357PubMed Berg P, Lindhardt BØ (2012) The role of procalcitonin in adult patients with community-acquired pneumonia—a systematic review. Dan Med J 59(3):A4357PubMed
22.
Zurück zum Zitat Maniaci V, Dauber A, Weiss S et al (2008) Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 122(4):701–710PubMedCrossRef Maniaci V, Dauber A, Weiss S et al (2008) Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 122(4):701–710PubMedCrossRef
23.
Zurück zum Zitat Fioretto JR, Borin FC, Bonatto RC et al (2007) Procalcitonin in children with sepsis and septic shock. J Pediatr (Rio J) 83(4):323–328CrossRef Fioretto JR, Borin FC, Bonatto RC et al (2007) Procalcitonin in children with sepsis and septic shock. J Pediatr (Rio J) 83(4):323–328CrossRef
24.
Zurück zum Zitat Gomez B, Bressan S et al (2012) Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics 130(5):815–822PubMedCrossRef Gomez B, Bressan S et al (2012) Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics 130(5):815–822PubMedCrossRef
25.
Zurück zum Zitat Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206–217PubMedCrossRef Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206–217PubMedCrossRef
26.
Zurück zum Zitat Gendrel D, Assicot M, Raymond J et al (1996) Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128(4):570–573PubMedCrossRef Gendrel D, Assicot M, Raymond J et al (1996) Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128(4):570–573PubMedCrossRef
27.
Zurück zum Zitat Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4(10):620–630PubMedCrossRef Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4(10):620–630PubMedCrossRef
28.
Zurück zum Zitat Vouloumanou EK, Plessa E, Karageorgopoulos DE et al (2011) Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 37(5):747–762PubMedCrossRef Vouloumanou EK, Plessa E, Karageorgopoulos DE et al (2011) Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 37(5):747–762PubMedCrossRef
29.
Zurück zum Zitat Chiesa C, Pellegrini G et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49(1):60–68PubMedCrossRef Chiesa C, Pellegrini G et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49(1):60–68PubMedCrossRef
30.
Zurück zum Zitat Vazzalwar R, Pina-Rodrigues E, Puppala BL et al (2005) Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol 25(6):397–402PubMedCrossRef Vazzalwar R, Pina-Rodrigues E, Puppala BL et al (2005) Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol 25(6):397–402PubMedCrossRef
31.
Zurück zum Zitat Turner D, Hammerman C, Rudensky B et al (2006) Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 91(4):F283–F286PubMedCrossRefPubMedCentral Turner D, Hammerman C, Rudensky B et al (2006) Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 91(4):F283–F286PubMedCrossRefPubMedCentral
32.
Zurück zum Zitat Lopez Sastre JB, Solis DP, Serradilla VR et al (2007) Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr 7:9PubMedCrossRefPubMedCentral Lopez Sastre JB, Solis DP, Serradilla VR et al (2007) Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr 7:9PubMedCrossRefPubMedCentral
33.
Zurück zum Zitat Chiesa C, Panero A, Rossi N et al (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26(3):664–672PubMedCrossRef Chiesa C, Panero A, Rossi N et al (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26(3):664–672PubMedCrossRef
34.
Zurück zum Zitat Joram N, Muller JB, Denizot S (2011) Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis 30:1005–1013PubMedCrossRef Joram N, Muller JB, Denizot S (2011) Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis 30:1005–1013PubMedCrossRef
35.
Zurück zum Zitat Joram N, Boscher C, Denizot S et al (2006) Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 91(1):F65–F66PubMedCrossRefPubMedCentral Joram N, Boscher C, Denizot S et al (2006) Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 91(1):F65–F66PubMedCrossRefPubMedCentral
36.
Zurück zum Zitat Kordek A, Hałasa M, Podraza W (2008) Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin Chem Lab Med 46(8):1143–1148PubMedCrossRef Kordek A, Hałasa M, Podraza W (2008) Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin Chem Lab Med 46(8):1143–1148PubMedCrossRef
37.
Zurück zum Zitat National Collaborating Centre for Women's and Children's Health (UK) (2012) Antibiotics for early-onset neonatal infection. National Institute for Health and Clinical Excellence, RCOG Press, London National Collaborating Centre for Women's and Children's Health (UK) (2012) Antibiotics for early-onset neonatal infection. National Institute for Health and Clinical Excellence, RCOG Press, London
38.
Zurück zum Zitat Haque KN (2005) Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 6(3 Suppl):S45–S49PubMedCrossRef Haque KN (2005) Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 6(3 Suppl):S45–S49PubMedCrossRef
39.
Zurück zum Zitat Hofer N, Müller W, Resch B (2011) Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med 49(2):297–302PubMedCrossRef Hofer N, Müller W, Resch B (2011) Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med 49(2):297–302PubMedCrossRef
40.
Zurück zum Zitat Mims LC, Medawar MS, Grubb WR et al (1972) Predicting neonatal infections by evaluation of the gastric aspirate: a study in two hundred and seven patients. Am J Obstet Gynecol 114(2):232–238PubMed Mims LC, Medawar MS, Grubb WR et al (1972) Predicting neonatal infections by evaluation of the gastric aspirate: a study in two hundred and seven patients. Am J Obstet Gynecol 114(2):232–238PubMed
Metadaten
Titel
A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm
verfasst von
S. Lencot
B. Cabaret
G. Sauvage
C. Laurans
E. Launay
J.-L. Orsonneau
J. Caillon
C. Boscher
J.-C. Roze
C. Gras-Le Guen
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2014
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2065-3

Weitere Artikel der Ausgabe 7/2014

European Journal of Clinical Microbiology & Infectious Diseases 7/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.